Bickling Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$443K Buy
804
+1
+0.1% +$530 0.28% 67
2022
Q3
$408K Sell
803
-9
-1% -$5.04K 0.27% 67
2022
Q2
$441K Sell
812
-1
-0.1% -$550 0.28% 68
2022
Q1
$480K Buy
813
+1
+0.1% +$574 0.25% 74
2021
Q4
$542K Buy
812
+14
+2% +$8.74K 0.26% 70
2021
Q3
$456K Buy
798
+107
+15% +$58.7K 0.23% 73
2021
Q2
$349K Hold
691
0.16% 87
2021
Q1
$315K Sell
691
-143
-17% -$68.3K 0.16% 82
2020
Q4
$388K Buy
+834
New +$391K 0.24% 67

Other funds holding TMO

Bickling Financial Services's TMO Position: Q4 2022 in Review

Bickling Financial Services increased its Thermo Fisher Scientific (TMO) stake by 0.12% in Q4 2022, buying an estimated $530 and bringing the position to 804 shares worth $443K. The position accounts for 0.28% of the portfolio, ranked #67.

Bickling Financial Services first reported a position in TMO in Q4 2020 and has held it in 9 quarters since. The position peaked at $542K in Q4 2021. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Bickling Financial Services held 804 shares of Thermo Fisher Scientific worth $443K as of Q4 2022.
  • Bickling Financial Services bought 1 Thermo Fisher Scientific share in Q4 2022, an estimated $530.
  • Thermo Fisher Scientific made up 0.28% of Bickling Financial Services's portfolio in Q4 2022, its #67 holding.
  • Bickling Financial Services first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 9 quarters since.
  • Bickling Financial Services's Thermo Fisher Scientific position peaked at $542K in Q4 2021.
  • 2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Bickling Financial Services's 13F filing for Q4 2022, filed 31 Jan 2023.